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Natural killer (NK) 1 cells have been implicated as important mediators in the 
prevention of experimental tumor development and metastasis (1-6).  NK cells 
have also been suggested (7-9) as important components of the immune response 
against  virus-infected cells.  In  addition,  NK  cells have been found to  have a 
cytotoxic effect on certain normal target cells. Immature thymocytes (10-I 3), 
activated B  lymphocytes (14),  and  some bone  marrow cells  (10,  13,  15)  are 
known to be susceptible to lysis by NK cells or cloned killer cell lines mediating 
NK function. This may reflect a potential regulatory role for NK in the devel- 
opment and differentiation of lymphoid cells and hemopoietic stem cells.  Peri- 
toneal macrophages (10,  12,  16) and fetal fibroblasts (12) are also known to be 
susceptible to NK cells. 
We have been  studying NK-mediated lysis of lymphoma cells isolated from 
patients, and have found that lymphoma cells from all the patients tested were 
susceptible  to  autologous  and  healthy  donors'  short-term  cultured,  partially 
purified NK cells (17). During experiments studying the target cell selectivity of 
these NK cells, their broad spectrum of cytotoxicity for normal and malignant 
target cells has been demonstrated. In this paper, we describe the nature of these 
NK cells, particularly their target cell selectivity, kinetics of the development of 
cytotoxicity, and  the  monocyte-mediated regulation  of the  cytotoxicity. The 
results  show  that  1-d-cultured  NK  cells  lysed all  types of target  cells  tested, 
including normal T  and B lymphocytes, mitogen-induced T  and B blasts, mon- 
ocytes, larger granular lymphocytes (LGL), various types of leukemia and lym- 
phoma cells isolated from patients, and cultured cell lines. Freshly isolated NK 
cells were not or,  if anything, were far less  cytotoxic against the target cells, 
while  monocytes and  their  supernatants  added  during  the  culture  markedly 
inhibited the development of their cytotoxicity. 
The overall results suggest that, although NK cells have ability to lyse normal 
~Abbreviations  used  in  this  paper:  E,  sheep  erythrocytes;  En,  neuraminidase-treated  E;  E:T, 
eflector/target;  F-C,  FicolI-Conray; FCS,  fetal  calf serum;  IFN,  interferon;  LGL,  large  granular 
lymphocytes; mAb, monoclonal antibodies; NK, natural killer; PBMC, peripheral blood mononuclear 
cells. 
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and  malignant  target cells in  vivo, their  lytic activity is  regulated  by coexisting 
inonocytes. 
Materials and  Methods 
Purification of Various Subsets of Cells  from Peripheral Blood.  The procedure for puri- 
fication of various subsets of cells is depicted  in  Fig.  1.  Peripheral  blood mononuclear 
cells (PBMC) were obtained from healthy donors and patients with non-Hodgkin's lym- 
phoma by Ficoll-Conray (F-C) density gradients. To obtain monocytes, mononuclear cells 
suspended  in  RPMI  1640  medium with  10%  fetal calf serum (FCS)  were incubated in 
glass  dishes  for 45  rain  at  37°C,  then  gently  pipetted.  After nonadherent  cells  were 
removed, the cells in  the glass dishes were further pipetted, and loosely adherent cells 
were discarded.  Adherent cells were left for a few hours at 4°C in phosphate-buffered 
saline, then vigorously pipetted. The removed cells were used as monocytes, being >90% 
a-naphthyl  butyrate  esterase-positive,  (and  completely  inhibited  by  NaF).  To  avoid 
adherence  to the  plastic,  harvested  monocytes were  left in  polypropylene tubes.  Glass 
dish-nonadherent cells were applied to columns of nylon wool and incubated for 1 h at 
37°C.  Nylon  wool-nonadherent  cells were eluted  with  warm medium,  then  added  to 
Percoll (Pharmacia Fine Chemicals,  Uppsala, Sweden) density gradient solutions as de- 
scribed previously (I 7,  18).  To prepare density gradients,  Percoll was mixed in various 
concentrations with  10%  FCS-containing RPMI  1640 medium. The Percoll solutions, in 
volumes of 1.5  ml, were carefully layered into a  10-ml round-bottom test tube, starting 
with 40% Percoll (fraction 5) and graded by 2.5% concentration reductions to 30% Percoll 
on the top (fraction 0).  After the lymphocytes were added to the Percoll solutions, they 
were centrifugated at 650 g for 20 rain at room temperature. Each fraction was collected 
and washed twice. The lymphocytes from low-density fractions 1 and 2 were mixed and 
used  as  LGL-rich  lymphocytes.  The  LGL-rich lymphocytes contained  52-69%  (mean 
60%) LGL, as determined by staining with May-Griinwald-Giemsa. High-density fraction 
4  was used as T  lymphocytes. This fraction was >90%  positive for OKT3  monoclonal 
antibody (mAb), the pan-T marker. To further purify LGL, the LGL-rich lymphocytes 
were mixed with sheep erythrocytes (E) for 1 h at 29°C, and E rosette-negative cells were 
obtained by F-C sedimentation and used as purified LGL (18).  Purified  LGL contained 
88-95%  LGL. To obtain B lymphocytes, nylon fiber-retained cells were retrieved from 
the  fiber  by  vigorous  agitation  in  cold  phosphate-buffered  saline,  then  mixed  with 
neuraminidase-treated sheep erythrocytes (En) for 2 h at 4°C. En rosette-negative cells, 
used as B lymphocytes, were  75-90%  positive for surface Ig, and <5%  positive for a- 
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naphthyl butyrate esterase and E-rosette formation. In some experiments, T  and B blasts 
were  used as target cells. T  blasts were obtained by  3-d-culture of T  lymphocytes and 
1/100 the number of monocytes with phytohemagglutinin-P (Gibco Laboratories, Grand 
Island, NY) diluted 1  : 1,00(). B blasts were obtained by 3-d-culture of B lymphocytes with 
0.1%  (vol/vol) killed Staphylococcus aureus  Cowan  I  bacteria. In limited experiments, B 
blasts were further enriched in the interface between 25% and 27.5% of Percoll solutions 
after centrifugation at 650 g for 20 min. 
Characteristics of Patients and Tumor Cells.  Patients 1-4 had non-Hodgkin's lymphoma. 
The  diagnosis was based on  the working formulation of the  National Cancer  Institute 
(19).  Patient  1 had  B  cell  lymphoma  of large cell, immunoblastic type,  patient  2  had 
OKT4 +, helper/inducer T  cell lymphoma of large cell, immunoblastic type, and patients 
3 and 4 had B cell lymphoma of diffuse, large cell type. The percentage of malignant cells 
in the lymph nodes was determined from morphology and surface markers, and consti- 
tuted 80% or more in the specimens. Lymphoma cells biopsied were teased, suspended in 
Eagle's minimum essential medium containing 75% FCS and 10% dimethylsulfoxide, and 
stored in liquid nitrogen until use for target cells. Blood was obtained from the patients 
at  least  3  wk  after  the  cessation  of  therapy  to  minimize  the  effects  of  chemo-  and 
radiotherapy. 
Leukemic cells in the peripheral blood or bone marrow were separated from patients 
5-12  with  F-C  gradient  sedimentation.  Patients  with  >90%  leukemic  cells  in  their 
peripheral blood leukocytes or bone  marrow cells were selected as donors of leukemic 
cells. Diagnosis of acute leukemia was based on the French-American-British cooperative 
group designation (20). 
Cell lines used for target cells were as follows: K562, an erythroleukemia; MOLT-4, a 
T  cell  acute  lymphoblastic  leukemia;  Raji,  a  Burkitt's  lymphoma;  HL-60,  an  acute 
promyelocytic leukemia; BALL-l, a  B cell acute lymphoblastic leukemia; P815, a  mouse 
mastocytoma; and L 1210, a mouse leukemia. 
Assay for Cytotoxic Activity.  The assay for cytotoxic activity was a  5-h 51Cr-release test, 
as described elsewhere (17).  Unless otherwise stated, effector cells were  LGL-rich lym- 
phocytes that had been incubated for 20-24 h  in RPMI  1640 medium with  10%  FCS at 
37°C  in  humidified air containing  5%  CO2.  Target  cells were  T  and  B  lymphocytes, 
mitogen-induced T  and B blasts, monocytes, LGL, lymphoma and leukemia cells isolated 
from  the patients, and  various cell lines.  Normal  unstimulated target cells were  either 
fresh or 1-d-cultured cells. Their susceptibility to effector cells was not different. Experi- 
ments  were  performed in  triplicate. For the labeling of target cells in  the S~Cr-release 
assay, 3  mCi of Na2"~CrO4  (sp act 20-200  mCi/mg; Japan  Isotope Association, Tokyo) 
was diluted with 1.5 ml of RPMI  1640 medium containing 10% FCS, and 50 ~Ci or 300- 
400 tlCi was incubated with  10  6 pelleted cells for 2 h.  50 #Ci were used for the labeling 
of cultured cell lines, and 300-400  #Ci for freshly isolated cells. The labeled cells were 
then washed three times, and used as target cells at 8  X  103 cells per microculture well. 
The  percent  specific 51Cr  release  was  calculated according  to  the  following formula: 
percent release =  100 X (experimental release -  spontaneous release)/(maximum release 
-  spontaneous  release), where  spontaneous  release was the  5~Cr  release from  8  x  103 
labeled target  cells incubated alone in  RPMI  1640  medium  containing  10%  FCS, and 
maximum  release was  that  from  labeled cells incubated alone in  water containing  5% 
detergent. The standard deviation of percent specific 5~Cr release was <5%  in most of 
•  •  51~  •  the experiments. Maximum release of  Cr from normal unstmaulated blood mononuclear 
cells was  1,000-4,000  cpm,  that  from  T  and  B  blasts was  2,000-8,000  cpm,  and  that 
from  lymphoma and  leukemia cells isolated from  patients was  1,000-7,000  cpm.  The 
amount of 5~Cr incorporated into cells depended on  the specific activity of ~Cr.  When 
~Cr having specific activity of 200-400 mCi/mg Cr was used instead of 20-200 mCi/mg 
Cr, a  much  higher level of 5~Cr was incorporated into normal unstimulated target cells 
and malignant cells isolated from patients, and similar results were obtained in terms of 
the value of percent specific ~Cr  release.  However,  this ~Cr  was not  used thereafter, 
because of its higher  cost.  Spontaneous release relative to  maximum  release was  37% 
(mean) in  T  lympbocytes, 30%  in  B  lymphocytes, 35%  in monocytes,  35%  in purified OSHIMI  ET  AL.  475 
LGL,  19%  in T  blasts,  29%  in  B blasts,  33%  in  lymphoma cells,  and  35%  in leukemia 
cells.  In  some experiments,  500  IU/ml of interferon  (IFN)-~ (sp act  2  x  107  IU  per 
milligram of protein) was added and incubated for 20-24 h with the effector cells.  IFN 
was not directly cytotoxic to the target cells during a 5~Cr-release  assay. Cytotoxic activity 
was  considered positive when  the  value of experimental  5~Cr release  was significantly 
above that of spontaneous 5~Cr release by the Student's t test. 
Characterization of  Effector Cells.  To determine whether the lymphocytes reactive with 
autologous blood mononuclear cells were NK cells or not,  the following methods were 
employed. First,  we determined whether  Percoll-sedimented fractions having high  NK 
activity against K562 cells also had high cytotoxic activity against the autologous blood 
mononuclear cells.  Effector cells  were  whole  mononuclear cells,  nylon  fiber column- 
passed  cells,  and  Percoll-sedimented  fractions  1-4.  In  three  similar experiments,  the 
percentages of LGL in each of the fractions were as follows; whole mononuclear cells, 
11-15%; nylon fiber-passed cells,  15-21%; Percoll fraction  1, 76-84%; fraction 2, 35- 
53%; fraction 3,  5-12%; and fraction 4, 2-6%. Percoll fractions 0 and 5 were not used 
as effector cells because these fractions contained many platelets and erythrocytes, respec- 
tively, and a  small number of lymphocytes. Second,  we determined whether  LGL-rich 
effector cells depleted of NK cells by mAb Leu-I lb (21), or of T  cells by mAb OKT3 
had cytotoxic activity against autologous blood mononuclear cells.  The panning method 
described by Payne et al. (22) was modified as follows: 3-ml quantities of affinity-purified 
F(ab')2 fragment goat anti-mouse IgG or IgM (Cappel Laboratories, West Chester, PA) 
were  added  to  60-mm  Petri  dishes  (Falcon  Labware,  Oxnard,  CA).  After  overnight 
incubation at 4°C, the antibody was harvested from the plates, and each plate was washed 
three times with 3 ml of cold medium. 107 LGL-rich lymphocytes, resuspended inl ml of 
l:10-diluted  Leu-1 lb or OKT3 mAb were incubated on ice for 30 min, washed, resus- 
pended in 2.5 ml of RPMI 1640 medium containing 5% FCS, and added to the antibody- 
coated plates.  Because  Leu-1 lb and  OKT3  are  IgM and  IgG antibodies,  respectively, 
Leu-1 lb-treated cells were added to anti-mouse IgM antibody-coated plates, and OKT3- 
treated cells were added to anti-mouse IgG antibody-coated plates. The plates were then 
incubated in a 5% CO2 incubator at 37°C for 30 min. The nonadherent cells (Leu-1 lb- 
or OKT3- cells) were harvested by swirling the plates and removing the cells by aspiration 
with a  Pasteur  pipette.  The cells were centrifuged,  and  the pellet was resuspended  in 
RPMI 1640 medium containing 10% FCS. The concentration of cells was readjusted, and 
the cells were used as effector cells for the cytotoxicity assay. In preliminary experiments, 
>95% of the Leu-1 lb  ÷ or OKT3 + cells were removed by the panning method when the 
cells were assayed by the indirect immunofluorescence method. 
Results 
Cytotoxicity of LGL-rich Lymphocytes  for Autologous Normal Blood Mononuclear 
Cells.  LGL-rich  lymphocytes  were  cultured  for  1  d  and  were  assayed  for 
cytotoxicity against autologous normal  blood mononuclear target cells in a  5-h 
5~Cr-release assay (Table I). Effector cells were obtained from normal individuals. 
Target cells were autologous  T  and  B  lymphocytes, mitogen-induced  T  and  B 
blasts,  monocytes,  LGL, and an  NK-sensitive cell line,  K562.  The results dem- 
onstrated that all target cells were lysed by LGL-rich effector cells. In 10 repeated 
experiments  in  which  unstimulated  T  and  B  lymphocytes were  simultaneously 
used as target cells,  B cells were more susceptible in  7  experiments, and T  cells 
in 2. B lymphocytes and monocytes had almost the same degree of susceptibility, 
and  T  lymphocytes and  LGL were  less susceptible  in  most of the  experiments. 
To  determine  whether  blastic  cells  were  more  susceptible  than  unstimulated 
cells,  T  and  B  blasts were  compared  with  unstimulated  T  and  B  lymphocytes. 
The results suggested that the blasts were less susceptible. 
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TABLE  1 
Autologous Cellular Lysis'by LGL-rich Lymphocytes 
Exp.  Target cells 
Cytotoxicity at effector/tar- 
get (E:T) ratios of: 
80:1  20:1 
% 
T lymphocytes  24  7 
B lymphocytes  44  23 
Monocytes  41  17 
LGL  25  15 
K562 cell line  ND*  71 
T lymphocytes  51  19 
T blasts*  23  16 
B lymphocytes  40  19 
B blasts*  28  7 
B blasts*  36  29 
B blasts, enriched ~  29  5 
LGL-rich lymphocytes obtained from normal individuals were cultured 
for  1 d and  assayed for their cytotoxicity against autologous  normal 
blood mononuclear cells and a K562 cell line. 
* ND, not done. 
* Morphologically identified blasts were 70-80% pure. 
§ B blasts were enriched to 95% by Percoll density gradient centrifugation. 
and Malignant  Target Cells.  Because  LGL-rich lymphocytes were cultured  for 
20-24  h  before  use  as  effector  cells  in  the  cytotoxicity  assay,  we  wished  to 
determine  whether  LGL-rich  effector  cells  were  also  cytotoxic  without  short- 
term culture. Table II shows that fresh effector cells did not lyse, or less efficiently 
lysed autologous B lymphocytes, monocytes and patients' tumor cells, the higher 
lytic activity being demonstrated in 20-24 h of culture. In patient 3,  1-d-cultured 
effector cells, but not fresh effector cells, lysed autologous lymphoma cells. 
Demonstration  of Cytotoxicity  with  Medium  Supplemented  with  AB  Serum  and 
Autologous  Serum.  Because  1-d-cultured  effector cells but not freshly prepared 
effector  cells  efficiently  lysed  the  target  cells,  we  questioned  whether  certain 
factor(s)  contained  in  FCS  would  induce  the  cytotoxic activity  in  vitro.  Thus, 
medium  supplemented  with  10%  heat-inactivated  human  AB  or  autologous 
serum  was  used  throughout  the  experiments.  Table  III  shows  that  cytotoxic 
activity  was  also  demonstrated  for  autologous  B  lymphocytes and  monocytes, 
and  allogeneic  lymphoma and  leukemia cells using  medium containing  human 
AB and autologous serum. Freshly prepared effector cells were not cytotoxic or 
only slightly cytotoxic, as was shown in the experiments using FCS-supplemented 
n~edium (data not shown). 
Characterization  of Cytotoxic Effector  Cells.  The  identity  of the  effector cells 
responsible  for the  observed cytotoxicity was determined.  First,  we conducted 
an  experiment to determine  whether  a  highly enriched population  of NK cells 
had cytotoxic activity for autologous  blood mononuclear cells (Table  IV).  The 
fractions  enriched  in  LGL  showed  a  considerable  increase  in  cytotoxicity  for 
autologous cells and  K562  cells, and  the cytotoxicity was almost parallel  to the OSHIM!  ET  AL.  477 
TABLE  II 
Reduced  Cytotoxicity of Freshly Prepared LGL-rich Lymphocytes Against 
Normal and Malignant Target Cells 
Cytotoxicity mediated by: 
Fresh effector cells at  1-d-cultured effector cells 
Target cells  E:T ratios of:  at E:T ratios of: 
80:1  20:1  80:1  20:1 
% 
B lymphocytes  7*  5*  46*  14" 
Monocytes  2  2  42*  20* 
Lymphoma cells: 
Patient  1  5*  0  44*  24* 
2  8*  ND  42*  ND 
3  0  0  13"  3 
LGL-rich lymphocytes from a normal individual and patient 3 were prepared, 
and their lytic activity was assayed, both immediately, and after 1 d of culture, 
for autologous B lymphocytes, monocytes, and lymphoma cells (patient 3) and 
for allogeneic lymphoma cells (patients  1 and 2).  Effector cells for lymphoma 
cells of patients  1 and 2 were from the normal donor. 
* Percentage of cytotoxicity in a 5~Cr-release  assay in which the value of released 
~lCr was  significantly (p <  0.05)  higher than  that of spontaneously released 
51Cr ' 
TABLE  III 
Effective Induction of Cytotoxic Effector Cells by Medium Supplemented  with Human AB Serum 
or Autologous Serum 
Exp.  Serum  Target cells 
Cytotoxicity at E:T 
ratios of: 
80:1  20:1 
1  AB  B lymphocytes  42  14 
Monocytes  49  7 
Lymphoma cells 
Patient 2  30  17 
Patient 3  14  6 
2  Autologous  B lymphocytes  29  7 
Monocytes  15  8 
Lymphoma cells from patient 2  26  20 
Leukemic blasts from patient 7  19  5 
LGL-rich lymphocytes from normal individuals were cultured for 1 d and assayed in their cytotoxicity 
for autologous B lymphocytes and monocytes, and allogeneic lymphoma and leukemia cells. Medium 
supplemented with 10% heat-inactivated human AB serum or autologous serum was used throughout 
the experiments, except when T  lymphocytes were removed by E rosetting during the procedure of 
target B cell preparation, in which case FCS-supplemented medium was used. 
concentration  of LGL.  Secondly,  LGL-rich  iymphocytes  were  treated  with mAb 
Leu-llb  or  OKT3,  and  NK  cells  or  T  cells  were  depleted  by  the  panning 
method.  The  nonadherent  Leu-llb-  or  OKT3-  cells  were  tested  for  their 
cytotoxicity  on  autologous  B  lymphocytes  and  monocytes,  and  K562  cells.  As 
shown  in  Table  V,  treatment  with  Leu-1 lb  markedly  inhibited  the cytotoxicity, 
whereas  the  remova[  of OKT3  +  cells did not  inhibit  the cytotoxicity,  indicating 478  NATURAL  KILLER  CELLS HAVE  BROAD  CYTOTOXIC1TY SPECTRA 
TABLE  IV 
Characterization of Cytotoxic Effector Cells by Percoll Discontinuous Gradient Centrifugation 
Effector cells  E:T ratio* 
Cytotoxicity for different target cells 
T  B  B blasts  Monocytes  LGL  K562" 
Whole mononuclear cells 
% 
80:1  -2  -2  -2  -8  -6  26 
20:1  -1  -1  -2  -5  -2  I0 
Nonadherent cells  80:1  -2  7  ND  -1  4  32 
20:1  2  4  ND  -3  -1  12 
Percollfraction 1  80:1  22  55  35  45  24  79 
20:1  12  26  6  10  7  50 
2  80:1  7  36  15  16  8  52 
20:1  1  11  -1  -2  1  18 
3  80:1  3  2  2  -3  -2  7 
20:1  2  0  -3  -5  -1  2 
4  80:1  3  1  2  -5  0  2 
20:1  1  -1  1  -4  1  1 
* E:T ratios were 80:1 and 20:1, except for K562 target cells, in which the E:T ratios were 20:1 and 
5:1. 
TABLE  V 
Characterization of Cytotoxic Effector Cells by Negative Selection with *nab 
Cytotoxicity against target cells 
Treatment of el-  B lymphocytes at E:T  Monocytes at E:T ra-  K562 cells at E:T ra- 
lector cells  ratios of:  tios of:  tios of: 
80:1  20:1  80:1  20:1  20:1  5:1 
% 
Control  23  13  31  4  49  12 
Leu-11 b  8  5  11  -2  4  0 
OKT3  21  14  40  7  61  19 
LGL-rich lymphocytes were incubated with Leu-1 lb or OKT3 mAb, and Leu-1 lb  ÷ or OKT3  + cells 
were depleted by adhering to anti-lg-coated  plates. In control treatment, cells without mAb treatment 
were applied to anti-lg-coated plates. 
that  mainly  Leu-llb +  NK  cells  mediated  cytotoxicity  for  autologous  blood 
mononuclear target cells. 
Regulation of Cytotoxicity by Monocytes  and Their Supernatants.  Because whole 
mononuclear cells did  not  lyse autologous normal mononuclear cells,  whereas 
fractions enriched with LGL did so efficiently (Table IV), we questioned whether 
the  latter positive results were  obtained because of the  removal of suppressor 
cells  during  the  preparation  of  LGL,  and/or  enrichment of the  effector  cell 
population. Because monocytes were removed during the preparation of effector 
cells, and because there are some reports (23-27) indicating monocyte-mediated 
NK suppression, we tested whether monocytes added in culture could suppress 
the development of lytic activity for normal and malignant target cells. As shown 
in Fig. 2, monocytes added to autologous LGL-rich effector cells at the beginning 
of culture significantly suppressed the lytic activity for autologous B lymphocytes OSHIMI  ET  AL.  479 
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FIGURE 2.  Inhibition of NK activity by monocytes.  LGL-rich effector cells from  normal 
individuals were cultured for 1 d with and without graded numbers ofautologous monocytes 
or T lymphocytes, and assayed for their cytotoxicity  against autologous B lymphocytes (A) and 
autologous monocytes (B), with an E:T ratio of 80:1. Monocytes (O------O) or T  lymphocytes 
(O---O)  were  added  at  the  beginning  of and  throughout  the  culture,  and  monocytes 
(O----  -  ----O)  were added only during the cytotoxicity assay. 
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FIGURE 3.  Inhibition of NK activity by monocytes. LGL-rich lymphocytes from patient 1 
(A), patient 4 (B), and two normal donors (C and D) were cultured for 1 d, with and without 
graded numbers of monocytes or T  lymphocytes, and assayed for their cytotoxicity against 
autologous lymphoma cells (A and B) and allogeneic lymphoma cells of patient  1 (C) and 
patient 2  (D).  The  E:T  ratio was  80:1.  Inhibitor cells  were added as follows: autologous 
monocytes added throughout the period of culture (O---------O)  or only during the cytotoxicity 
assay (O----  - --0); allogeneic monocytes added throughout the period of culture (X  x); 
and autologous T  lymphocytes (O-----E))  and allogeneic T  lymphocytes were (E)-----Q)  added 
throughout  the  period of culture.  When  effector cells were from  the patients, allogeneic 
inhibitor cells added were from normal donors, and vice versa. 
and  monocytes,  whereas  monocytes  added  only  during  the  cytotoxicity assay 
suppressed the activity less prominently.  Lytic activity was not suppressed by the 
addition  of  T  lymphocytes.  When  LGL-rich  lymphocytes  obtained  from  the 
patients  with  malignant  lymphoma  were  cultured  for  1  d  with  autologous 
patients'  and  allogeneic  healthy  donors'  monocytes,  monocytes  from  both  au- 
tologous and allogeneic donors suppressed lytic activity for autologous lymphoma 
cells (Fig.  3).  Likewise,  killer activity of healthy donors'  LGL-rich lymphocytes 
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and allogeneic patients' monocytes. The degree of suppression was almost similar 
between  monocytes derived  from the  patients  and  those  derived  from healthy 
donors, indicating that the presence of such monocytes is not limited to patients 
with malignant disease. 
To  further  clarify  the  mechanism  of  monocyte-mediated  NK  suppression, 
supernatants  of  1-d-cultured  monocytes  and  T  lymphocytes  were  added  to 
effector cells at the  beginning of culture  or only during  the  cytotoxicity assay. 
Table VI shows that supernatants of monocytes, but not those of T  lymphocytes 
suppressed the  development of cytotoxicity for autologous  B  lymphocytes. Cy- 
totoxicity  for  allogeneic  tumor  cells  was  also  suppressed.  The  results  indicate 
that  suppression  was  mediated  by factor(s) released  from monocytes.  Superna- 
tants  added  only  during  the  cytotoxicity  assay  less  efficiently  suppressed  the 
cytotoxicity. Thus,  a  more prolonged period of contact was required  to induce 
a  full  degree  of  suppression  of effector  cell  reactivity.  When  the  degree  of 
suppression was compared between monocytes and their supernatants, monocytes 
suppressed  more prominently.  This  may reflect  the  fact that  monocytes acted 
partly as an unlabeled competitive inhibitor for 5~Cr-labeled target cells, because 
monocytes themselves were susceptible targets of NK cells. 
Lysis of Leukemic  Cells by LGL-rich Lymphocytes.  To examine the  target spec- 
trum of cytotoxicity of LGL-rich lymphocytes, we tested whether leukemic cells 
isolated from patients would be susceptible to healthy donors' LGL-rich lympho- 
cytes. Table VII shows that all the types of leukemic cells tested were susceptible 
to  l-d-cultured  effector  cells,  whereas  most  of them  were  less  susceptible  to 
freshly isolated effector cells.  Moreover,  monocytes added  throughout  the  cul- 
ture period completely suppressed the development of cytotoxic activity. 
Susceptibility  of Cell Lines to LGL-rich Lymphocytes.  To  further  delineate  the 
target selectivity of LGL-rich effector cells, in vitro-maintained cell lines, includ- 
ing those relatively resistant to lysis by NK cells, were tested for their susceptibility 
"FABLE  VI 
Suppression of Cytotoxicity by Supernatants of Cultured Monocytes 
Exp.  Target cells 
Dura-  Cytotoxicity in presence of inhibitors:* 
tion  Mono-  Monocyte  Monocyte  Monocyte  T  T cell 
added*  None  cytes  sup 2X  sup 1X  sup V2X  cells sup 2X 
1  B cells 
d  % 
1  41  -3  8  17  27  33  37 
CRT  14  34  37  42  36  41 
2  B cells  1  39  9  19 
Leukemic  1  40  8  11 
myeloblasts 
L(;L-rich lymphocytes fi'om normal donors were cultured for 1 d with or without inhibitors, and 
assayed f~)r their cytotoxicity against autologous B lymphocytes and patient's leukemic myeloblasts 
at an E:T ratio of 80:1. 
* I)uration of time inhibitors were added:  1 d denotes that inhibitors were added at the beginning 
of culture; CRT denotes that they were added only during the 5~Cr-release test. 
* lnhibitors added  were as follows: autologous monocytes or T  lymphocytes of 1/2 the number of 
l.GL-rich effector  cells; supernatants  (sup) of 1-d-cultured monocytes or T  lymphocytes having 
final concentrations of cells of two, one, and V2 times those added to LGL-rich effector cells. OSHIMI  ET  AL.  481 
TABLE  VII 
Lysis of Patients' Leukemic Cells by LGL-rich Lymphocytes, and 
Suppression of Their Lyric Activity by Monocytes 
Cytotoxicity mediated by: 
Target cells  Fresh effector cells  1-d-cultured cells at E:T ra- 
from patient*  at E:T ratios of:  tios of: 
80:1  20:1  80:1  20:1  80:1' 
% 
5 (M1)  ND  ND  270  60  -6 
6 (M1)  7 §  4  31 §  12  ~  2 
7 (M2)  ND  ND  47  ~  30  §  ND 
8 (M3)  4 §  4  36  §  15  §  3 
9 (M5)  9 §  6 j  50  4  -5 
10 (L1)  5 §  1  430  210  -8 
11 (L1)  3  2  330  16  §  -1 
12 (ATL)  4  1  80  4  -9 
LGL-rich lymphocytes from healthy individuals were assayed, immedi- 
ately after preparation and again after  1 d  of culture,  for cytotoxicity 
against leukemic cells isolated from patients. 
* Target cells were  leukemic cells obtained from  patients.  Diagnosis of 
acute leukemia was based on the FAB designation (20): M 1, myeloblastic 
leukemia without maturation; M2, myeloblastic leukemia with matura- 
tion; M3,  hypergranular promyelocytic leukemia;  M5,  monocytic leu- 
kemia; and L1, lymphoblastic leukemia characterized by small, homo- 
geneous blasts. ATL is adult T  cell leukemia. 
* Monocytes of V2 the number of effector cells were added at the begin- 
ning of culture. 
§ Percentage of cytotoxicity in a  5~Cr-release assay in which the value of 
released 51Cr  was significantly (p <  0.05)  higher than that of sponta- 
neously released ~Cr. 
to LGL-rich lymphocytes. Table VIII shows that 1-d-cultured effector cells lysed 
all the cell lines tested. P815 and L1210, which were resistant to lysis by freshly 
isolated LGL-rich lymphocytes, were also lysed by  1-d-cultured LGL-rich lym- 
phocytes. L1210, which was resistant to lysis by IFN-activated blood mononuclear 
cells,  was  also  susceptible  to  the  1-d-cultured  LGL-rich  effector  cells.  The 
addition of monocytes inhibited the development or enhancement of cytotoxicity 
of LGL-rich effector cells for all the cell lines tested. 
Discussion 
In this study, we demonstrate the presence of NK cells with a broad spectrum 
of cytotoxicity for normal and malignant target cells, and describe the monocyte- 
mediated  regulation  of their  cytotoxicity. There  has  been  no  earlier  report 
concerning the  NK-mediated lysis  of autologous normal  blood  mononuclear 
cells.  There may be several reasons why such findings have not been reported 
previously: (a), NK-enriched fractions were used as effector cells in our experi- 
ments. When whole mononuclear cells, instead of LGL-rich lymphocytes, were 
used as effector cells,  cytotoxicity was not elicited (Table IV). (b), T  blasts were 
mostly used as target cells by others; when blasts and unstimulated cells  were 
compared, blasts  were  less  susceptible targets.  (c), Cytotoxicity was efficiently 482  NATURAL  KILLER CELLS  HAVE  BROAD  CYTOTOXICITY SPECTRA 
TABLE  VIII 
Lysis of Cultured Cell Lines by PBMC and LGL-rich Lymphocytes 
Cytotoxicity mediated by: 
Target cell  E:T ratio  1-d LGL 
lines  Fresh  1-d  1-d PBMC  Fresh  1-d 
PBMC  PBMC  plus IFN-/3*  LGL  LGL  plus mono- 
cytes* 
% 
K562  20:1  40  51  82  61  82  60 
5:1  14  17  48  28  45  ND 
MOLT-4  20:1  24  31  72  53  71  47 
5:1  12  17  39  32  48  ND 
Raji  80:1  3  4  49  15  61  12 
20:1  1  4  34  6  23  ND 
HL-60  80:1  1  -1  67  36  78  18 
20:1  2  -1  37  15  52  ND 
BALL-1  80:1  -1  0  62  34  86  12 
20:1  1  2  53  12  50  ND 
P815  80:1  1  2  54  1  22  1 
20:1  0  2  36  0  8  ND 
L1210  80:1  -1  -1  4  2  33  2 
20:1  -1  0  3  1  8  ND 
Freshly isolated and 1-d-cultured PBMC and LGL-rich lymphocytes were assayed for their cytotox- 
icity against various cultured cell lines. 
* 500 IU/ml IFN-/3 was added to PBMC throughout the culture period. 
* Monocytes of 1/z the number of LGL-rich lymphocytes were added throughout the culture. 
demonstrated only after a  short period of culture; freshly prepared  NK cells did 
not  possess,  or  only  slightly  possessed  such  cytotoxicity.  (d),  Because  of poor 
incorporation  of 5~Cr into unstimulated  normal  target cells as compared to that 
of transformed cells, unstimulated  cells have not usually been used as target cells 
by other workers. This problem of poor 5~Cr incorporation was partially resolved 
in  our experiments  by labeling  pellets  of target  cells  with  highly active  5~Cr of 
300-400  uCi. 
With  regard  to  the  nature  of effector  cells,  fractions  enriched  in  LGL  had 
higher cytotoxicity (Table I V), and depletion of Leu-1 1 b + ceils markedly reduced 
cytotoxicity (Table  V), indicating that mainly NK cells mediated cytotoxicity for 
autologous  normal  blood  mononuclear  cells.  Similar  results  were  obtained  in 
autologous  and  allogeneic  systems  of lymphoma  cell  lysis  (17).  Furthermore, 
competitive  inhibition  studies  using  unlabeled  target  cells  showed that cytotox- 
icity was  efficiently  inhibited  by the  addition  of unlabeled  K562  cells,  and  less 
efficiently  by  L1210  cells,  suggesting  that  killer  cells  reactive  with  autologous 
normal cells were  included  within  the  population  of killer  cells  that  were  more 
reactive with  K562 than  L1210 cells (data not shown). 
With  regard  to the nature  of target cells,  some T  and  B  lymphocytes,  T  and OSHIMI ET AL.  483 
B blasts, monocytes, and LGL were lysed by NK cells. Thus it may be important 
to  elucidate exactly which  T  cells  or other cells are susceptible  to  NK  cells. 
Because not all of the LGL are NK cells (18),  LGL other than NK cells may be 
susceptible to NK cells, or this might be one of the negative regulatory mecha- 
nisms of NK activation. In addition to normal target cells, NK cells showed lytic 
activity for malignant cells isolated from patients. Although we did not determine 
whether patients' NK cells would be able to lyse autologous leukemic blasts, NK 
cells lysed autologous lymphoma cells in all the patients tested (17), and NK ceils 
from normal individuals lysed lymphoma (17)and  leukemia cells (Table VII). 
Included among the susceptible malignant cells were T  and B lymphoma cells, 
leukemic myeloblasts, promyelocytes, monoblasts, and lymphoblasts. Leukemic 
monoblasts from patient 9 were less sensitive to lysis than normal monocytes. Of 
various cell lines tested, murine L1210  leukemic cells, which were resistant to 
lysis by IFN-activated blood  mononuclear cells (presumably IFN-activated NK 
cells), were also lysed by short-term cultured LGL-rich iymphocytes (Table VIII). 
Thus LGL-rich lymphocytes lysed NK-resistant cell lines, indicating their broad 
spectrum of target cell selectivity. 
Kinetic studies revealed that lytic activity was readily demonstrated after 1 d 
of culture, and freshly prepared effector cells did not lyse, or less efficiently lysed 
target cells (Table II). Furthermore, a similar level of cytotoxicity for autologous 
B lymphocytes was persistent after 3 d ofcuhure, and the cytotoxicity was present 
even after 1 wk of culture, although the level of cytotoxicity was lower (data not 
shown). Because FCS has been reported (28-30) to augment NK activity, medium 
supplemented with AB serum or autologous serum was used, and similar results 
were obtained (Table III). Thus, it is unlikely that certain factor(s) included in 
FCS  induced the cytotoxic activity in  vitro.  The possibility that cytophilic Ig, 
which might inhibit the lytic activity of NK cells in vivo, might be released from 
the  surface  of  NK  cells  after  a  short  term  of cuhure,  thus  enhancing  the 
cytotoxicity in vitro, cannot be ruled out (31). However, the overall results could 
be  explained  if monocytes coexisting with  LGL  in  the  peripheral  blood  are 
inhibiting  NK  activity  in  vivo,  and  the  removal  of monocytes unmasks  the 
presence of killer cells in a  short-term culture. Indeed, there have been many 
reports (23-27) describing monocyte-mediated NK suppression.  In our experi- 
ments,  monocytes added  at  the  beginning of culture  markedly inhibited  the 
development of cytotoxicity (Fig.  2).  Using medium supplemented with human 
AB serum or autologous serum, monocytes added at the beginning of culture 
also inhibited the development of cytotoxicity (data not shown).  Furthermore, 
supernatants of cultured monocytes inhibited the development of cytotoxicity 
(Table VI). Thus, monocyte-mediated inhibition was shown to be due to factor(s) 
released from monocytes. The nature of the inhibitory factor(s) remains to be 
elucidated.  In  preliminary  experiments,  indomethacin  or  catalase  added  to 
monocytes did not abrogate the monocyte-mediated inhibition, suggesting that 
neither prostaglandins (23, 25) nor hydrogen peroxide (24) plays an important 
role. Because monocytes were susceptible targets for NK cells, the possibility that 
target structures present on  the surface of monocytes and recognized by NK 
effector cells were shed into the medium during culture, subsequently blocking 
the receptor sites of effector cells, cannot be ruled out. 484  NATURAL  KILLER  CEI.LS  HAVE  BROAD  CYTOTOXICITY  SPECTRA 
Whether  NK  cells  having  the  ability  to  lyse  autologous  normal  cells  and 
malignant  cells  are  actually  present  in  vivo  is  an  important  issue.  Although 
indirectly suggested, the NK lytic process seems to be involved in the mechanism 
of NK suppression  of antibody-producing cells in vivo (32), and animal experi- 
ments indicate NK-mediated lysis of tumor cells in vivo (4,  33,  34). Therefore, 
if monocytes play a  central role in NK regulation, changes in these regulatory 
mechanisms may lead to the development, exacerbation, or regression of such 
diseases as malignant neoplasms and autoimmune diseases. 
Summary 
After depletion of monocytes, natural killer (NK) cells were partially purified 
from peripheral blood by Percoll density gradient sedimentation. The NK cells 
were  then  cultured  for  1  d  and  assayed for  their  cytotoxicity against  various 
types of normal and malignant target cells. All types of target cells tested were 
found to be susceptible to NK cells. The susceptible targets were autologous T 
and B lymphocytes, mitogen-induced T  and B blasts, monocytes, large granular 
lymphocytes, autologous  or  allogeneic  lymphoma and  leukemia  cells  isolated 
from patients,  and  cultured  cell  lines,  including those  resistant  to  interferon- 
activated lymphocytes. Such a broad spectrum of cytotoxicity was demonstrated 
in  1  d  of culture,  and  freshly  prepared  NK  cells  were  not  cytotoxic,  or,  if 
anything, were less cytotoxic. Monocytes and their supernatants, added through- 
out the course of culture, markedly inhibited the development of their cytotox- 
icity. These  results  may suggest that, although  NK  ceils  having ability to  lyse 
autologous  normal  and  malignant  target  cells  are  present  in  vivo,  their  lytic 
activity is regulated by coexisting monocytes. 
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